Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Study of VI-0521 on Ambulatory Blood Pressure (ABPM) in Overweight or Obese Subjects

ClinicalTrials.gov ID: NCT05215418

Public ClinicalTrials.gov record NCT05215418. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 6:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind Study to Compare the Effects of VI-0521,Phentermine, and Placebo on Ambulatory Blood Pressure in Overweight or Obese Subjects

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study is being conducted to evaluate the effect of VI-0521 (Qsymia®) on blood pressure as measured by 24-hour ambulatory blood pressure monitoring, compared to both placebo and an active control (phentermine 30 mg).

Study identification

NCT ID
NCT05215418
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
VIVUS LLC
Industry
Enrollment
565 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 25, 2022 (Actual)
Primary completion
Apr 11, 2023 (Actual)
Completion
Apr 17, 2023 (Actual)
Last update posted
Jul 17, 2024

2022 – 2023

United States locations

U.S. sites
28
U.S. states
17
U.S. cities
28
Facility City State ZIP Site status
Clinical Site Anniston Alabama 36207 —
Clinical Site Mobile Alabama 36608 —
Clinical Site Lincoln California 95648 —
Clinical Site Long Beach California 90806 —
Clinical Site Sacramento California 95821 —
Clinical Site Spring Valley California 91978 —
Clinical Site Upland California 91786 —
Clinical Site Washington D.C. District of Columbia 20011 —
Clinical Site Coral Gables Florida 33134 —
Clinical Site Miami Florida 33155 —
Clinical Site Port Orange Florida 23227 —
Clinical Site Brownsburg Indiana 46112 —
Clinical Site Evansville Indiana 47714 —
Clinical Site Wichita Kansas 67207 —
Clinical Site Lexington Kentucky 40509 —
Clinical Site Louisville Kentucky 40213 —
Clinical Site Baton Rouge Louisiana 70808 —
Clinical Site Kansas City Missouri 64114 —
Clinical Site Butte Montana 59701 —
Clinical Site Cary North Carolina 27518 —
Clinical Site Eugene Oregon 97404 —
Clinical Site Columbia South Carolina 29223 —
Clinical Site Knoxville Tennessee 37920 —
Clinical Site Friendswood Texas 77546 —
Clinical Site North Richland Hills Texas 76180 —
Clinical Site San Antonio Texas 78215 —
Clinical site Salt Lake City Utah 84124 —
Clinical Site Norfolk Virginia 23502 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05215418, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 17, 2024 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05215418 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →